Inhibikase Therapeutics Stock Price History

IKT Stock  USD 2.37  0.05  2.07%   
If you're considering investing in Inhibikase Stock, it is important to understand the factors that can impact its price. As of today, the current price of Inhibikase Therapeutics stands at 2.37, as last reported on the 22nd of March, with the highest price reaching 2.46 and the lowest price hitting 2.36 during the day. Inhibikase Therapeutics holds Efficiency (Sharpe) Ratio of -0.0146, which attests that the entity had a -0.0146 % return per unit of risk over the last 3 months. Inhibikase Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inhibikase Therapeutics' Market Risk Adjusted Performance of 0.8625, insignificant risk adjusted performance, and Standard Deviation of 7.09 to validate the risk estimate we provide.
  
Inhibikase Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0146

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIKT

Estimated Market Risk

 7.09
  actual daily
63
63% of assets are less volatile

Expected Return

 -0.1
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Inhibikase Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inhibikase Therapeutics by adding Inhibikase Therapeutics to a well-diversified portfolio.

Inhibikase Therapeutics Stock Price History Chart

There are several ways to analyze Inhibikase Stock price data. The simplest method is using a basic Inhibikase candlestick price chart, which shows Inhibikase Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 3, 20253.32
Lowest PriceJanuary 30, 20251.92

Inhibikase Therapeutics March 22, 2025 Stock Price Synopsis

Various analyses of Inhibikase Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Inhibikase Stock. It can be used to describe the percentage change in the price of Inhibikase Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Inhibikase Stock.
Inhibikase Therapeutics Price Rate Of Daily Change 0.98 
Inhibikase Therapeutics Price Action Indicator(0.06)
Inhibikase Therapeutics Price Daily Balance Of Power(0.50)

Inhibikase Therapeutics March 22, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Inhibikase Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Inhibikase Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Inhibikase Stock and then apply it to test your longer-term investment strategies against Inhibikase.

Inhibikase Stock Price History Data

The price series of Inhibikase Therapeutics for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 1.4 with a coefficient of variation of 14.84. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.59. The median price for the last 90 days is 2.47. The company completed 1:6 stock split on 30th of June 2023.
OpenHighLowCloseVolume
03/22/2025
 2.42  2.46  2.36  2.37 
03/21/2025 2.42  2.46  2.36  2.37  112,818 
03/20/2025 2.45  2.58  2.35  2.42  109,201 
03/19/2025 2.37  2.56  2.34  2.47  171,743 
03/18/2025 2.41  2.42  2.27  2.37  155,512 
03/17/2025 2.25  2.40  2.24  2.36  175,997 
03/14/2025 2.21  2.26  2.13  2.25  71,825 
03/13/2025 2.26  2.26  2.08  2.20  109,884 
03/12/2025 2.19  2.26  2.12  2.23  72,456 
03/11/2025 1.94  2.21  1.94  2.20  91,072 
03/10/2025 1.93  2.22  1.91  1.99  155,073 
03/07/2025 2.11  2.15  1.93  1.96  184,914 
03/06/2025 2.19  2.29  2.09  2.11  102,113 
03/05/2025 2.21  2.50  2.17  2.23  117,710 
03/04/2025 2.23  2.23  2.07  2.20  179,751 
03/03/2025 2.30  2.53  2.27  2.27  117,765 
02/28/2025 2.32  2.54  2.23  2.30  326,393 
02/27/2025 2.41  2.43  2.31  2.34  92,049 
02/26/2025 2.23  2.46  2.23  2.38  120,350 
02/25/2025 2.45  2.50  2.17  2.24  194,183 
02/24/2025 2.82  2.89  2.38  2.48  247,727 
02/21/2025 3.32  3.32  2.93  2.97  266,630 
02/20/2025 3.08  3.32  2.99  3.26  283,467 
02/19/2025 2.61  3.10  2.52  3.08  261,011 
02/18/2025 2.28  2.64  2.28  2.60  228,028 
02/14/2025 2.21  2.38  2.21  2.35  122,528 
02/13/2025 2.29  2.33  2.20  2.23  91,162 
02/12/2025 2.25  2.39  2.25  2.26  139,272 
02/11/2025 2.40  2.45  2.34  2.34  156,200 
02/10/2025 2.25  2.51  2.25  2.44  256,730 
02/07/2025 2.42  2.53  2.31  2.35  154,401 
02/06/2025 2.35  2.53  2.29  2.43  239,541 
02/05/2025 2.22  2.34  2.19  2.33  156,996 
02/04/2025 2.16  2.28  2.07  2.27  159,356 
02/03/2025 2.20  2.37  2.03  2.16  227,847 
01/31/2025 1.90  2.29  1.90  2.27  442,326 
01/30/2025 2.17  2.59  1.91  1.92  982,581 
01/29/2025 2.75  2.85  2.71  2.80  430,040 
01/28/2025 2.69  2.78  2.66  2.76  81,947 
01/27/2025 2.82  2.85  2.66  2.74  84,282 
01/24/2025 2.86  2.90  2.74  2.81  80,767 
01/23/2025 2.79  2.96  2.73  2.83  119,298 
01/22/2025 2.80  2.84  2.71  2.80  80,658 
01/21/2025 2.76  2.89  2.62  2.81  126,380 
01/17/2025 2.77  2.85  2.67  2.72  39,867 
01/16/2025 2.76  2.90  2.55  2.76  92,417 
01/15/2025 2.70  2.84  2.68  2.73  83,398 
01/14/2025 2.75  2.98  2.59  2.66  86,646 
01/13/2025 2.85  3.03  2.66  2.66  147,978 
01/10/2025 3.00  3.10  2.86  2.95  178,433 
01/08/2025 3.25  3.35  3.06  3.10  102,078 
01/07/2025 3.11  3.34  3.11  3.21  190,718 
01/06/2025 3.25  3.47  3.15  3.16  301,905 
01/03/2025 3.36  3.36  3.11  3.32  188,735 
01/02/2025 3.49  3.49  3.14  3.29  82,807 
12/31/2024 3.36  3.49  3.04  3.25  200,894 
12/30/2024 3.05  3.24  2.96  3.24  132,322 
12/27/2024 3.04  3.12  2.91  3.05  59,475 
12/26/2024 2.95  3.10  2.90  3.06  101,900 
12/24/2024 2.92  3.05  2.92  2.96  66,079 
12/23/2024 3.23  3.23  2.90  2.96  176,073 

About Inhibikase Therapeutics Stock history

Inhibikase Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inhibikase is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inhibikase Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inhibikase Therapeutics stock prices may prove useful in developing a viable investing in Inhibikase Therapeutics
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinsons Disease and related disorders that arise inside and outside of the brain. Inhibikase Therapeutics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia. Inhibikase Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.

Inhibikase Therapeutics Stock Technical Analysis

Inhibikase Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Inhibikase Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Inhibikase Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module

Inhibikase Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Inhibikase Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Inhibikase Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inhibikase to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Inhibikase Stock Analysis

When running Inhibikase Therapeutics' price analysis, check to measure Inhibikase Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibikase Therapeutics is operating at the current time. Most of Inhibikase Therapeutics' value examination focuses on studying past and present price action to predict the probability of Inhibikase Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibikase Therapeutics' price. Additionally, you may evaluate how the addition of Inhibikase Therapeutics to your portfolios can decrease your overall portfolio volatility.